London Daily

Focus on the big picture.
Wednesday, Oct 22, 2025

European Union Turns To Pfizer After Johnson & Johnson Vaccine Suspension

European Union Turns To Pfizer After Johnson & Johnson Vaccine Suspension

BioNTech/Pfizer is bringing forward delivery of 50 million doses to the second quarter, starting this month, to help make up for the shortfall of the J&J jabs that were meant to start rolling out, she said in a televised statement.

The EU is turning more heavily to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for longer-term needs to fight the mutating coronavirus, its chief Ursula von der Leyen said Wednesday.

BioNTech/Pfizer is bringing forward delivery of 50 million doses to the second quarter, starting this month, to help make up for the shortfall of the J&J jabs that were meant to start rolling out, she said in a televised statement.

The European Union is also negotiating with BioNTech/Pfizer for 1.8 billion doses of a second-generation of its mRNA vaccine to combat variants, to be delivered in 2022 and 2023, she said.

"As we can see, with the announcement by Johnson & Johnson yesterday, there are still many factors that can disrupt the planned delivery schedules of vaccines," she said, referring to the company's decision to suspend European deliveries while rare blood clot cases possibly linked to its shot are investigated in the United States.

"It is therefore important to act swiftly, anticipate and adjust whenever it is possible," she said, announcing the second-quarter delivery of 50 million BioNTech/Pfizer doses originally scheduled for the fourth quarter of this year.

Von der Leyen said that would bring the total number of BioNTech/Pfizer doses for April, May and June to 250 million -- accounting for more than half of all jabs to be given in this quarter.

"I think this will substantially help consolidate the rollout of our vaccination campaigns," she said, noting that there have already been 100 million doses given in the bloc to date, with 27 million people fully vaccinated.

The European Union had a sluggish first-quarter rollout mainly because of vaccine supply constraints, especially by AstraZeneca which delivered less than a quarter of the 120 million doses it had promised.

Virus variants


Question marks are now above the adenovirus-type vaccines produced by AstraZeneca and Johnson & Johnson in the wake of suspected blood clots.

While the European Medicines Agency has authorised AstraZeneca for all adults, many EU countries have taken the precaution of limiting its use to only older segments of the population.

Von der Leyen made clear that BioNTech/Pfizer was increasingly the go-to supplier for the bloc, with no health problems so far associated with its mRNA vaccine which has proven to be highly effective against the main strains of the coronavirus present in the EU.

However there are concerns about emerging virus variants that could dampen the effect of current vaccines.

Von der Leyen said to address that, "at a certain point in time, we might need booster jabs to reinforce and prolong immunity" with vaccines that are effective against mutations.

"We need to focus now on technologies that have proven their worth: mRNA vaccines are a clear case in point. And based on all this, we are now entering into negotiations with BioNTech/Pfizer for a third contract," she said.

That would foresee the delivery of 1.8 billion second-generation BioNTech/Pfizer vaccine doses over next year and 2023.

"It will entail not only the production of vaccines, but also the essential components. All of that will be based in the European Union," von der Leyen said, indirectly referencing concerns that had arisen about supplies of AstraZeneca from Britain or Johnson & Johnson doses that were sent via the US for packaging.

The EU has made the production of vaccines on its territory -- already the main vaccine manufacturing powerhouse in the world alongside the US -- a condition of its forthcoming contracts.

"Other contracts with other companies may follow," von der Leyen said.

Newsletter

Related Articles

0:00
0:00
Close
‘Frightening’ First Night in Prison for Sarkozy: Inmates Riot and Shout ‘Little Nicolas’
White House Announces No Imminent Summit Between Trump and Putin
US and Qatar Warn EU of Trade and Energy Risks from Tough Climate Regulation
Apple Challenges EU Digital Markets Act Crackdown in Landmark Court Battle
Nicolas Sarkozy begins five-year prison term at La Santé in Paris
Japan stocks surge to record as Sanae Takaichi becomes Prime Minister
This Is How the 'Heist of the Century' Was Carried Out at the Louvre in Seven Minutes: France Humiliated as Crown with 2,000 Diamonds Vanishes
China Warns UK of ‘Consequences’ After Delay to London Embassy Approval
France’s Wealthy Shift Billions to Luxembourg and Switzerland Amid Tax and Political Turmoil
"Sniper Position": Observation Post Targeting 'Air Force One' Found Before Trump’s Arrival in Florida
Shouting Match at the White House: 'Trump Cursed, Threw Maps, and Told Zelensky – "Putin Will Destroy You"'
Windows’ Own ‘Siri’ Has Arrived: You Can Now Talk to Your Computer
Thailand and Singapore Investigate Cambodian-Based Prince Group as U.S. and U.K. Sanctions Unfold
‘No Kings’ Protests Inflate Numbers — But History Shows Nations Collapse Without Strong Executive Power
Chinese Tech Giants Halt Stablecoin Launches After Beijing’s Regulatory Intervention
Manhattan Jury Holds BNP Paribas Liable for Enabling Sudanese Government Abuses
Trump Orders Immediate Release of Former Congressman George Santos After Commuting Prison Sentence
S&P Downgrades France’s Credit Rating, Citing Soaring Debt and Political Instability
Ofcom Rules BBC’s Gaza Documentary ‘Materially Misleading’ Over Narrator’s Hamas Ties
Diane Keaton’s Cause of Death Revealed as Pneumonia, Family Confirms
Former Lostprophets Frontman Ian Watkins Stabbed to Death in British Prison
"The Tsunami Is Coming, and It’s Massive": The World’s Richest Man Unveils a New AI Vision
Outsider, Heroine, Trailblazer: Diane Keaton Was Always a Little Strange — and Forever One of a Kind
Dramatic Development in the Death of 'Mango' Founder: Billionaire's Son Suspected of Murder
Two Years of Darkness: The Harrowing Testimonies of Israeli Hostages Emerging From Gaza Captivity
EU Moves to Use Frozen Russian Assets to Buy U.S. Weapons for Ukraine
Europe Emerges as the Biggest Casualty in U.S.-China Rare Earth Rivalry
HSBC Confronts Strategic Crossroads as NAB Seeks Only Retail Arm in Australia Exit
U.S. Chamber Sues Trump Over $100,000 H-1B Visa Fee
Shenzhen Expo Spotlights China’s Quantum Step in Semiconductor Self-Reliance
China Accelerates to the Forefront in Global Nuclear Fusion Race
Yachts, Private Jets, and a Picasso Painting: Exposed as 'One of the Largest Frauds in History'
Australia’s Wedgetail Spies Aid NATO Response as Russian MiGs Breach Estonian Airspace
McGowan Urges Chalmers to Cut Spending Over Tax Hike to Close $20 Billion Budget Gap
Victoria Orders Review of Transgender Prison Placement Amid Safety Concerns for Female Inmates
U.S. Treasury Mobilises New $20 Billion Debt Facility to Stabilise Argentina
French Business Leaders Decry Budget as Macron’s Pro-Enterprise Promise Undermined
Trump Claims Modi Pledged India Would End Russian Oil Imports Amid U.S. Tariff Pressure
Surging AI Startup Valuations Fuel Bubble Concerns Among Top Investors
Australian Punter Archie Wilson Tears Up During Nebraska Press Conference, Sparking Conversation on Male Vulnerability
Australia Confirms U.S. Access to Upgraded Submarine Shipyard Under AUKUS Deal
“Firepower” Promised for Ukraine as NATO Ministers Meet — But U.S. Tomahawks Remain Undecided
Brands Confront New Dilemma as Extremists Adopt Fashion Labels
The Sydney Sweeney and Jeans Storm: “The Outcome Surpassed Our Wildest Dreams”
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
Dutch Government Seizes Chipmaker After U.S. Presses for Removal of Chinese CEO
×